Market Access & Reimbursement
Clarify funding pathways, evidence expectations, value narratives and pricing risks before critical decisions are fixed.
China & Asia-Pacific Healthcare Strategy
From Market Access Strategy to Commercial Execution
ACCESSBRIDGE helps healthcare innovators navigate reimbursement, market entry, commercialization and cross-border growth across China and Asia-Pacific — turning complex healthcare systems into practical paths to access and sustainable growth.
Market AccessAt the core of strategy
China + APACCross-market perspective
Founder-LedSenior-level delivery
Strategy to ExecutionPractical paths forward
The Challenge
Healthcare Growth Is a System Challenge
A strong product, a reimbursement submission or a distribution partner is rarely enough on its own. Sustainable growth depends on how policy priorities, evidence, funding pathways, clinical practice, stakeholder incentives and commercial execution work together.
Market Entry & Commercialization
Connect market potential, product–market fit, stakeholder strategy and launch readiness into one executable growth plan.
Cross-Border Growth
Build partnership strategies around credible access pathways, strategic fit and long-term value creation.
How We Help
Three Ways We Support Healthcare Growth
APAC Market Access & Reimbursement
Senior strategic support for companies with local or regional commercial or market access teams that need deeper market access expertise or additional leadership capacity.
Explore this service →China Market Entry & Commercialization
End-to-end support for global healthcare companies entering or expanding in China, with or without an established local team.
Explore this service →Cross-Border Strategic Partnering
Global product scouting and market access-informed partnership support for China-based healthcare companies and global innovators pursuing cross-border growth.
Explore this service →Why ACCESSBRIDGE
Strategy That Connects Policy, Evidence and Commercial Reality
ACCESSBRIDGE combines system-level market access thinking with real-world commercial execution. We translate science into policy relevance, policy priorities into market opportunities, and strategy into actions that teams can implement.
Why ACCESSBRIDGE →How We Work
Built to Work as an Extension of Your Team
Some clients need a senior advisor for a critical decision. Others need an embedded project partner to lead a workstream, align functions or build launch capability.
01
Strategic Advisor
Senior guidance for a defined decision or leadership question.
Senior guidance for a defined decision or leadership question.
02
Embedded Project Partner
Hands-on support that works alongside the client team.
Hands-on support that works alongside the client team.
03
Workstream Lead
Cross-functional leadership from fact base to execution.
Cross-functional leadership from fact base to execution.
04
Team Coach
Frameworks and capability that remain with the organization.
Frameworks and capability that remain with the organization.
Selected APAC Market Access Achievements
Policy Insight Translated into Measurable Results
Selected achievements personally led by ACCESSBRIDGE’s founder in prior China and APAC leadership roles. Together, they demonstrate the pricing, reimbursement, evidence strategy and execution capabilities ACCESSBRIDGE brings to client engagements.
National and Local Reimbursement Achievements
Secured reimbursement listings at national, provincial and municipal levels across China, expanded reimbursement coverage for an implant from 10% to 80%, and maintained stable pricing nationwide. These achievements demonstrate ACCESSBRIDGE’s ability to navigate China’s multi-level reimbursement system, optimize reimbursement benefits and translate national strategy into local execution.
50%+ Pricing Uplift
Applied pricing analysis and value strategy to achieve a 50%+ reimbursement price increase for a group of medical consumables—demonstrating the ability to translate reimbursement mechanics into sustainable commercial value.
20% Reimbursement Premium
Secured reimbursement at a 20% premium without direct comparative studies by building a credible evidence and value case—demonstrating ACCESSBRIDGE’s capabilities in evidence strategy, value communication and payer engagement.
Eligible Population Tripled
Expanded reimbursement eligibility across additional patient groups, tripling the eligible population. The work demonstrates how policy criteria, clinical evidence and stakeholder strategy can unlock meaningful access growth.
20% Reimbursement Price Protection
Translated reimbursement rules into quantified business impact, maintaining the product’s full reimbursement price and protecting 20% of its value. This policy-to-business approach helps clients anticipate pricing impact and sustain long-term product value.
10% Reimbursement Premium
Secured reimbursement at a 10% premium without direct comparative studies through local evidence development and value communication—demonstrating how a focused access strategy can support differentiated pricing.
Double-Digit Business Growth
Developed policy-driven hospital communication tools that supported double-digit business growth—demonstrating how reimbursement insight can be converted into practical tools for commercial and hospital teams.
Founder-Led
Senior Experience, Directly Applied
ACCESSBRIDGE was founded by Ziyan Wang, a healthcare market access, policy and commercialization strategist with nearly two decades of experience spanning public health and the healthcare industry, including pharmaceuticals, medical devices, diagnostics and vision care. Her early foundations at LSE and WHO continue to shape a system-level, globally connected approach to client work.
Meet the Founder →Start a Conversation
Let’s Build a Clearer Path to Access and Growth
Tell us where you are trying to go — and what is getting in the way.